U.S. equities were mixed in midday trading Friday, though remained on track to close out with their best monthly gain in four years. Stocks have rallied in October as crude oil recovered from lows, and China and the European Central Bank committed to stimulus to reinvigorate growth. Drugstore chain CVS Health (CVS) led S&P 500 decliners after it guided for weaker-than-expected earnings over fiscal 2016. The company has managed to boost pharmacy sales even as its drugstore business suffers after ceasing all tobacco sales. Chicago business activity bounced back into positive territory in October. Chicago PMI rebounded to its highest level since January, boosted by gains in new orders and production.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.